Loading...

Matthew Kirkpatrick, PhD

Title(s)Assistant Professor of Research Preventive Medicine
Phone+1 323 442 8221
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Matt Kirkpatrick, PhD is an Assistant Professor of Research in the Department of Preventive Medicine in the Keck School of Medicine at the University of Southern California. He is associate director of the USC-Health, Emotion, & Addiction Laboratory (USC-HEAL), which conducts interdisciplinary research at the intersection between drug abuse, emotion, and health-related behaviors. He earned his B.A. in Religious Studies at the University of North Carolina at Chapel Hill and Ph.D. in Psychology at Columbia University. Dr. Kirkpatrick completed postdoctoral training in neuropsychopharmacology at the University of Chicago.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Leventhal AM, Goldenson NI, Cho J, Kirkpatrick MG, McConnell RS, Stone MD, Pang RD, Audrain-McGovern J, Barrington-Trimis JL. Flavored E-cigarette Use and Progression of Vaping in Adolescents. Pediatrics. 2019 Nov; 144(5). PMID: 31659004.
      View in: PubMed
    2. Pang RD, Guillot CR, Liautaud MM, Bello MS, Kirkpatrick MG, Huh J, Leventhal AM. Subjective effects from the first cigarette of the day vary with precigarette affect in premenopausal female daily smokers. Exp Clin Psychopharmacol. 2019 Aug 01. PMID: 31368771.
      View in: PubMed
    3. Leventhal AM, Goldenson NI, Barrington-Trimis JL, Pang RD, Kirkpatrick MG. Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers. Drug Alcohol Depend. 2019 Oct 01; 203:99-106. PMID: 31434028.
      View in: PubMed
    4. Kirkpatrick MG, Cruz TB, Unger JB, Herrera J, Schiff S, Allem JP. Cartoon-based e-cigarette marketing: Associations with susceptibility to use and perceived expectations of use. Drug Alcohol Depend. 2019 Aug 01; 201:109-114. PMID: 31207451.
      View in: PubMed
    5. Majmundar A, Kirkpatrick M, Cruz TB, Unger JB, Allem JP. Characterising KandyPens-related posts to Instagram: implications for nicotine and cannabis use. Tob Control. 2019 May 30. PMID: 31147484.
      View in: PubMed
    6. Guillot CR, Blackledge SM, Douglas ME, Cloutier RM, Liautaud MM, Pang RD, Kirkpatrick MG, Leventhal AM. Indirect Associations of Anxiety Sensitivity with Tobacco, Alcohol, and Other Drug Use Problems Through Emotional Disorder Symptoms in Adolescents. Behav Med. 2019 Apr 30; 1-9. PMID: 31039083.
      View in: PubMed
    7. Leventhal AM, Goldenson NI, Aguirre CG, Huh J, Kirkpatrick MG. Initial application of a human laboratory model for estimating the motivational substitutability of e-cigarettes for combustible cigarettes. Exp Clin Psychopharmacol. 2019 Apr; 27(2):125-135. PMID: 30688503.
      View in: PubMed
    8. Chu KH, Allem JP, Unger JB, Cruz TB, Akbarpour M, Kirkpatrick MG. Strategies to find audience segments on Twitter for e-cigarette education campaigns. Addict Behav. 2019 Apr; 91:222-226. PMID: 30497815.
      View in: PubMed
    9. Escobedo P, Cruz TB, Tsai KY, Allem JP, Soto DW, Kirkpatrick MG, Pattarroyo M, Unger JB. Monitoring Tobacco Brand Websites to Understand Marketing Strategies Aimed at Tobacco Product Users and Potential Users. Nicotine Tob Res. 2018 09 25; 20(11):1393-1400. PMID: 29059386.
      View in: PubMed
    10. Bello MS, McBeth JF, Ditre JW, Kirkpatrick MG, Ray LA, Dunn KE, Leventhal AM. Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. J Abnorm Psychol. 2018 Oct; 127(7):683-694. PMID: 30070540.
      View in: PubMed
    11. Allem JP, Cruz TB, Unger JB, Toruno R, Herrera J, Kirkpatrick MG. Return of cartoon to market e-cigarette-related products. Tob Control. 2019 Sep; 28(5):555-557. PMID: 30049688.
      View in: PubMed
    12. Pester MS, Kirkpatrick MG, Geary BA, Leventhal AM. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers. J Psychopharmacol. 2018 03; 32(3):302-308. PMID: 29338486.
      View in: PubMed
    13. MacKillop J, Goldenson NI, Kirkpatrick MG, Leventhal AM. Validation of a behavioral economic purchase task for assessing drug abuse liability. Addict Biol. 2019 Mar; 24(2):303-314. PMID: 29314376.
      View in: PubMed
    14. Pang RD, Liautaud MM, Kirkpatrick MG, Huh J, Monterosso J, Leventhal AM. Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory. Neuropsychopharmacology. 2018 03; 43(4):828-837. PMID: 28905874.
      View in: PubMed
    15. Guillot CR, Halliday TM, Kirkpatrick MG, Pang RD, Leventhal AM. Anhedonia and Abstinence as Predictors of the Subjective Pleasantness of Positive, Negative, and Smoking-Related Pictures. Nicotine Tob Res. 2017 Jun 01; 19(6):743-749. PMID: 28186553.
      View in: PubMed
    16. Chuang CI, Sussman S, Stone MD, Pang RD, Chou CP, Leventhal AM, Kirkpatrick MG. Impulsivity and history of behavioral addictions are associated with drug use in adolescents. Addict Behav. 2017 11; 74:41-47. PMID: 28570913.
      View in: PubMed
    17. Kirkpatrick MG, Cruz TB, Goldenson NI, Allem JP, Chu KH, Pentz MA, Unger JB. Electronic cigarette retailers use Pokémon Go to market products. Tob Control. 2017 12; 26(e2):e145-e147. PMID: 28044010.
      View in: PubMed
    18. Leventhal AM, Kirkpatrick MG, Pester MS, McGeary JE, Swift RM, Sussman S, Kahler CW. Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology (Berl). 2017 Jan; 234(2):307-315. PMID: 27771748.
      View in: PubMed
    19. Goldenson NI, Kirkpatrick MG, Barrington-Trimis JL, Pang RD, McBeth JF, Pentz MA, Samet JM, Leventhal AM. Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology. Drug Alcohol Depend. 2016 Nov 01; 168:176-180. PMID: 27676583.
      View in: PubMed
    20. Francis SM, Kirkpatrick MG, de Wit H, Jacob S. Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration. Psychoneuroendocrinology. 2016 12; 74:92-100. PMID: 27592327.
      View in: PubMed
    21. Wolitzky-Taylor K, McBeth J, Guillot CR, Stone MD, Kirkpatrick MG, Zvolensky MJ, Buckner JD, Leventhal AM. Transdiagnostic processes linking anxiety symptoms and substance use problems among adolescents. J Addict Dis. 2016 Oct-Dec; 35(4):266-277. PMID: 27431313.
      View in: PubMed
    22. Sussman S, Chou CP, Pang RD, Kirkpatrick M, Guillot CR, Stone M, Khoddam R, Riggs NR, Unger JB, Leventhal AM. Social Self-Control Is a Statistically Nonredundant Correlate of Adolescent Substance Use. Subst Use Misuse. 2016 05 11; 51(6):788-94. PMID: 27070833.
      View in: PubMed
    23. Pang RD, Kirkpatrick MG, Goldenson NI, Guillot CR, Leventhal AM. Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures. Pharmacol Biochem Behav. 2016 May; 144:73-7. PMID: 26952590.
      View in: PubMed
    24. Bershad AK, Weafer JJ, Kirkpatrick MG, Wardle MC, Miller MA, de Wit H. Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9. PMID: 26787430.
      View in: PubMed
    25. Pang RD, Bello MS, Stone MD, Kirkpatrick MG, Huh J, Monterosso J, Haselton MG, Fales MR, Leventhal AM. Premenstrual symptoms and smoking-related expectancies. Addict Behav. 2016 Jun; 57:38-41. PMID: 26869196.
      View in: PubMed
    26. Huh J, Cerrada CJ, Kirkpatrick MG, Dunton G, Leventhal AM. Social contexts of momentary craving to smoke among Korean American emerging adults. Addict Behav. 2016 May; 56:23-9. PMID: 26802789.
      View in: PubMed
    27. Leventhal AM, Strong DR, Sussman S, Kirkpatrick MG, Unger JB, Barrington-Trimis JL, Audrain-McGovern J. Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016 Feb; 73:71-8. PMID: 26688438.
      View in: PubMed
    28. Kirkpatrick MG, Goldenson NI, Kapadia N, Kahler CW, de Wit H, Swift RM, McGeary JE, Sussman S, Leventhal AM. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl). 2016 Jan; 233(1):89-97. PMID: 26429791.
      View in: PubMed
    29. van den Berg SM, de Moor MH, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, Huffman JE, Konte B, Lahti J, Lee M, Miller M, Nutile T, Tanaka T, Teumer A, Viktorin A, Wedenoja J, Abdellaoui A, Abecasis GR, Adkins DE, Agrawal A, Allik J, Appel K, Bigdeli TB, Busonero F, Campbell H, Costa PT, Smith GD, Davies G, de Wit H, Ding J, Engelhardt BE, Eriksson JG, Fedko IO, Ferrucci L, Franke B, Giegling I, Grucza R, Hartmann AM, Heath AC, Heinonen K, Henders AK, Homuth G, Hottenga JJ, Iacono WG, Janzing J, Jokela M, Karlsson R, Kemp JP, Kirkpatrick MG, Latvala A, Lehtimäki T, Liewald DC, Madden PA, Magri C, Magnusson PK, Marten J, Maschio A, Mbarek H, Medland SE, Mihailov E, Milaneschi Y, Montgomery GW, Nauck M, Nivard MG, Ouwens KG, Palotie A, Pettersson E, Polasek O, Qian Y, Pulkki-Råback L, Raitakari OT, Realo A, Rose RJ, Ruggiero D, Schmidt CO, Slutske WS, Sorice R, Starr JM, St Pourcain B, Sutin AR, Timpson NJ, Trochet H, Vermeulen S, Vuoksimaa E, Widen E, Wouda J, Wright MJ, Zgaga L, Porteous D, Minelli A, Palmer AA, Rujescu D, Ciullo M, Hayward C, Rudan I, Metspalu A, Kaprio J, Deary IJ, Räikkönen K, Wilson JF, Keltikangas-Järvinen L, Bierut LJ, Hettema JM, Grabe HJ, Penninx BW, van Duijn CM, Evans DM, Schlessinger D, Pedersen NL, Terracciano A, McGue M, Martin NG, Boomsma DI. Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium. Behav Genet. 2016 Mar; 46(2):170-82. PMID: 26362575.
      View in: PubMed
    30. Goldenson NI, Kirkpatrick MG, Leventhal AM. Initial Validation of the Pleasure and Health Behavior Inventory - A Measure of Motivation to Engage in Health-damaging Behavior to Overcome Deficient Pleasure. Am J Health Behav. 2015 Sep; 39(5):652-64. PMID: 26248175.
      View in: PubMed
    31. Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, Stone MD, Khoddam R, Samet JM, Audrain-McGovern J. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015 Aug 18; 314(7):700-7. PMID: 26284721.
      View in: PubMed
    32. de Moor MH, van den Berg SM, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, Huffman JE, Konte B, Lahti J, Lee M, Miller M, Nutile T, Tanaka T, Teumer A, Viktorin A, Wedenoja J, Abecasis GR, Adkins DE, Agrawal A, Allik J, Appel K, Bigdeli TB, Busonero F, Campbell H, Costa PT, Davey Smith G, Davies G, de Wit H, Ding J, Engelhardt BE, Eriksson JG, Fedko IO, Ferrucci L, Franke B, Giegling I, Grucza R, Hartmann AM, Heath AC, Heinonen K, Henders AK, Homuth G, Hottenga JJ, Iacono WG, Janzing J, Jokela M, Karlsson R, Kemp JP, Kirkpatrick MG, Latvala A, Lehtimäki T, Liewald DC, Madden PA, Magri C, Magnusson PK, Marten J, Maschio A, Medland SE, Mihailov E, Milaneschi Y, Montgomery GW, Nauck M, Ouwens KG, Palotie A, Pettersson E, Polasek O, Qian Y, Pulkki-Råback L, Raitakari OT, Realo A, Rose RJ, Ruggiero D, Schmidt CO, Slutske WS, Sorice R, Starr JM, St Pourcain B, Sutin AR, Timpson NJ, Trochet H, Vermeulen S, Vuoksimaa E, Widen E, Wouda J, Wright MJ, Zgaga L, Porteous D, Minelli A, Palmer AA, Rujescu D, Ciullo M, Hayward C, Rudan I, Metspalu A, Kaprio J, Deary IJ, Räikkönen K, Wilson JF, Keltikangas-Järvinen L, Bierut LJ, Hettema JM, Grabe HJ, van Duijn CM, Evans DM, Schlessinger D, Pedersen NL, Terracciano A, McGue M, Penninx BW, Martin NG, Boomsma DI. Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. JAMA Psychiatry. 2015 Jul; 72(7):642-50. PMID: 25993607.
      View in: PubMed
    33. Leventhal AM, Bello MS, Unger JB, Strong DR, Kirkpatrick MG, Audrain-McGovern J. Diminished Alternative Reinforcement as a Mechanism Underlying Socioeconomic Disparities in Adolescent Substance Use. Prev Med. 2015 Nov; 80:75-81. PMID: 26051200.
      View in: PubMed
    34. Bershad AK, Kirkpatrick MG, Seiden JA, de Wit H. Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12. PMID: 25853370.
      View in: PubMed
    35. Guillot CR, Stone MD, Geary BA, Kirkpatrick MG, Tidey JW, Cook JW, Leventhal AM. Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study. Hum Psychopharmacol. 2015 Sep; 30(5):364-71. PMID: 26010521.
      View in: PubMed
    36. Baggott MJ, Kirkpatrick MG, Bedi G, de Wit H. Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77. PMID: 25922420.
      View in: PubMed
    37. Kirkpatrick M, Delton AW, Robertson TE, de Wit H. Prosocial effects of MDMA: A measure of generosity. J Psychopharmacol. 2015 Jun; 29(6):661-8. PMID: 25735993.
      View in: PubMed
    38. Wolitzky-Taylor K, Guillot CR, Pang RD, Kirkpatrick MG, Zvolensky MJ, Buckner JD, Leventhal AM. Examination of anxiety sensitivity and distress tolerance as transdiagnostic mechanisms linking multiple anxiety pathologies to alcohol use problems in adolescents. Alcohol Clin Exp Res. 2015 Mar; 39(3):532-9. PMID: 25706521.
      View in: PubMed
    39. Kirkpatrick MG, de Wit H. MDMA: a social drug in a social context. Psychopharmacology (Berl). 2015 Mar; 232(6):1155-63. PMID: 25281223.
      View in: PubMed
    40. Kirkpatrick MG, Francis SM, Lee R, de Wit H, Jacob S. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology. 2014 Aug; 46:23-31. PMID: 24882155.
      View in: PubMed
    41. Wardle MC, Kirkpatrick MG, de Wit H. 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81. PMID: 24682132.
      View in: PubMed
    42. Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H. MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905. PMID: 24633447.
      View in: PubMed
    43. Kirkpatrick MG, Lee R, Wardle MC, Jacob S, de Wit H. Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63. PMID: 24448644.
      View in: PubMed
    44. Kirkpatrick MG, de Wit H. In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl). 2013 Nov; 230(2):215-26. PMID: 23712603.
      View in: PubMed
    45. Gunderson EW, Kirkpatrick MG, Willing LM, Holstege CP. Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine. J Addict Med. 2013 May-Jun; 7(3):163-8. PMID: 23732955.
      View in: PubMed
    46. Kirkpatrick MG, Johanson CE, de Wit H. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64. PMID: 23343596.
      View in: PubMed
    47. Kirkpatrick MG, Gunderson EW, Johanson CE, Levin FR, Foltin RW, Hart CL. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction. 2012 Apr; 107(4):783-91. PMID: 22050030.
      View in: PubMed
    48. Kirkpatrick MG, Gunderson EW, Levin FR, Foltin RW, Hart CL. Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):191-204. PMID: 21748253.
      View in: PubMed
    49. Kirkpatrick MG, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL. A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):109-22. PMID: 21713605.
      View in: PubMed
    50. Kirkpatrick MG, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL. Zolpidem does not serve as reinforcer in humans subjected to simulated shift work. Drug Alcohol Depend. 2010 Nov 01; 112(1-2):168-71. PMID: 20655669.
      View in: PubMed
    51. Kirkpatrick MG, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL. Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes. Psychopharmacology (Berl). 2009 May; 203(4):771-80. PMID: 19052727.
      View in: PubMed
    52. Perez AY, Kirkpatrick MG, Gunderson EW, Marrone G, Silver R, Foltin RW, Hart CL. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):258-62. PMID: 18078723.
      View in: PubMed
    53. Kirkpatrick MG, Metcalfe J, Greene MJ, Hart CL. Effects of intranasal methamphetamine on metacognition of agency. Psychopharmacology (Berl). 2008 Mar; 197(1):137-44. PMID: 18043908.
      View in: PubMed
    54. Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD, Foltin RW. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology. 2008 Jul; 33(8):1847-55. PMID: 17851535.
      View in: PubMed